Infectious Diseases 2018
Journal of Prevention and Infection Control
ISSN: 2471-9668
Page 45
June 07-08, 2018
London, UK
8
th
Edition of International Conference on
Infectious Diseases
T
he objectives of this study were to determine impacts of
hospital associated infections with invasive devices in a
tertiary care hospital, Bangkok, Thailand. This descriptive study
to determine impacts of hospital associated infections with
invasive devices of ventilator-associated pneumonia (VAP), central
line-associated bloodstream infection (CLABSI) and catheter-
associated urinary tract infection (CAUTI) including mortality rate,
case fatality rate, length of hospital stay, and direct cost of VAP,
CLABSI and CAUTI treatment of patients undergoing insertion
invasive devices who were admitted into 6 ICUs and 36 general
wards during October 2016 to September 2017. VAP, CLABSI
and CAUTI occurrence were collected by the researcher using
definition of the Centers for Disease Control and Prevention (CDC)
and followed daily until discharge fromhospital or death. Data were
analyzed using descriptive statistics. Mortality rate of VAP cases
was 7.4 per 100 mechanically ventilated patients. Case fatality
rate was 42.6 percent. Range of length of hospital stay was 5-246
days (Mode = 6 days). Eighty-nine percent of VAP cases developed
VAP after 6 days of receiving mechanical ventilation (late onset).
Total attributable cost of VAP was 103,285.56 USD. Mortality rate
of CLABSI cases was 8.6 per 100 central lines patients. Case
fatality rate was 51.9 percent. Range of length of hospital stay
was 7-182 days (Mode = 8 days). Total attributable cost of CLABSI
was 26,879.94 USD. Mortality rate of CAUTI cases was 1.7 per
100 catheter patients. Case fatality rate was 19.8 percent. Range
of length of hospital stay was 4-297 days. Total attributable cost
of CAUTI was 96,577.32 USD. The results revealed that impacts
of VAP, CLABSI and CAUTI to patients and hospitals. Hospital
personnel who take care of inserted invasive devices patients need
to realize the impacts of VAP, CLABSI, CAUTI and strictly follow
infection prevention activities.
Recent Publications
1. Al-Mousa H H, Omar A A, Rosenthal V D, Salama M F,
Aly N Y, Noweir M E D and George S M (2016) Device-
associated infection rates, bacterial resistance,
length of stay, and mortality in Kuwait: international
nosocomial infection consortium findings. American
Journal of Infection Control 44(4):444-449.
2. Gonzales M, Rocher I, Fortin É, Fontela P, Kaouache
M, Tremblay C and Quach C (2013) A survey of
preventive measures used and their impact on central
line-associated bloodstream infections (CLABSI) in
intensive care units (SPIN-BACC). BMC Infectious
Diseases 13(1):562.
3. Hu B, Tao L, Rosenthal V D, Liu K, Yun Y, Suo Y and Hao
C (2013) Device-associated infection rates, device use,
length of stay, and mortality in intensive care units of
4 Chinese hospitals: international nosocomial control
consortium findings. American Journal of Infection
Control 41(4):301-306.
4. Kumar S, Sen P, Gaind R, Verma, P K, Gupta P, Suri P
R and Rai A K (2017) Prospective surveillance of
device-associated health care–associated infection
in an intensive care unit of a tertiary care hospital in
New Delhi, India. American Journal of Infection Control
46(2):202-206
5. Mathai A S, Phillips A, Kaur P and Isaac R (2015)
Incidence and attributable costs of ventilator-
associated pneumonia (VAP) in a tertiary-level
intensive care unit (ICU) in northern India. Journal of
Infection and Public Health 8(2):127-135.
Biography
Jinjutha Kaewmak is a Professional Nurse. She works in the operating theater,
specializing in Ophthalmic Surgery and expertise in Nursing Care of Patients
with Infectious Diseases and Infection Control. Her present research is in Epi-
demiology and impacts of hospital-associated infections on older patients in
tertiary care hospitals and has participated in the 28
th
Annual AcademicMeeting
Rajavithi Hospital, Bangkok, Thailand. In 2017, she was responsible and partic-
ipated and she took part in project about effect of using collaborative quality
improvement of infection prevention in her hospital.
jinjutha56@gmail.comImpacts of hospital associated infections with invasive devices
in a tertiary care hospital, Bangkok, Thailand
Jinjutha Kaewmak
and
Kampong Kamnon
Rajavithi Hospital, Thailand
Jinjutha Kaewmak et al., J Prev Infect Cntrol 2018, Volume 4
DOI: 10.21767/2471-9668-C1-003